Notice: This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends SRNG vs. RVMD, HALO, KRYS, ADMA, ACLX, IMVT, SRRK, CRSP, DNLI, and VCELShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include Revolution Medicines (RVMD), Halozyme Therapeutics (HALO), Krystal Biotech (KRYS), ADMA Biologics (ADMA), Arcellx (ACLX), Immunovant (IMVT), Scholar Rock (SRRK), CRISPR Therapeutics (CRSP), Denali Therapeutics (DNLI), and Vericel (VCEL). Soaring Eagle Acquisition vs. Revolution Medicines Halozyme Therapeutics Krystal Biotech ADMA Biologics Arcellx Immunovant Scholar Rock CRISPR Therapeutics Denali Therapeutics Vericel Soaring Eagle Acquisition (NASDAQ:SRNG) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability. Does the media prefer SRNG or RVMD? In the previous week, Revolution Medicines had 11 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 11 mentions for Revolution Medicines and 0 mentions for Soaring Eagle Acquisition. Revolution Medicines' average media sentiment score of 0.62 beat Soaring Eagle Acquisition's score of 0.20 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Overall Sentiment Soaring Eagle Acquisition Neutral Revolution Medicines Positive Does the MarketBeat Community favor SRNG or RVMD? Revolution Medicines received 90 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformSoaring Eagle AcquisitionN/AN/ARevolution MedicinesOutperform Votes9075.63% Underperform Votes2924.37% Do insiders and institutionals believe in SRNG or RVMD? 41.2% of Soaring Eagle Acquisition shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 8.0% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is SRNG or RVMD more profitable? Soaring Eagle Acquisition's return on equity of 0.00% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Soaring Eagle AcquisitionN/A N/A N/A Revolution Medicines N/A -33.67%-30.08% Which has higher valuation and earnings, SRNG or RVMD? Soaring Eagle Acquisition has higher earnings, but lower revenue than Revolution Medicines. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoaring Eagle AcquisitionN/AN/AN/AN/AN/ARevolution Medicines$742K9,988.85-$436.37M-$3.59-12.27 Do analysts rate SRNG or RVMD? Revolution Medicines has a consensus target price of $65.82, suggesting a potential upside of 49.38%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts plainly believe Revolution Medicines is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 SummaryRevolution Medicines beats Soaring Eagle Acquisition on 10 of the 12 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$2.17B$2.94B$8.37B$9.08BDividend YieldN/A1.90%11.76%4.23%P/E RatioN/A46.7312.1817.18Price / SalesN/A415.0167.78117.05Price / CashN/A182.1010.9037.85Price / BookN/A3.893.384.78Net IncomeN/A-$42.21M$955.68M$225.60M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$10.08+15.3%N/A+472.7%$2.17BN/A0.00N/AGap DownRVMDRevolution Medicines4.4832 of 5 stars$45.75+2.3%$63.67+39.2%+67.7%$7.70B$742,000.00-12.45443Insider TradeHALOHalozyme Therapeutics4.9904 of 5 stars$48.60+1.2%$61.11+25.7%+27.3%$6.18B$947.36M15.90390Analyst ForecastPositive NewsKRYSKrystal Biotech4.5187 of 5 stars$167.29-0.2%$206.67+23.5%+41.2%$4.81B$241.52M94.69229Analyst ForecastADMAADMA Biologics3.7819 of 5 stars$18.85-0.7%$21.25+12.7%+321.3%$4.46B$382.81M67.32530Positive NewsGap DownACLXArcellx2.9744 of 5 stars$82.29-1.4%$105.93+28.7%+45.6%$4.45B$155.82M-117.49130Positive NewsIMVTImmunovant1.4396 of 5 stars$27.73+0.4%$47.89+72.7%-33.9%$4.07BN/A-12.45120Analyst ForecastNews CoverageSRRKScholar Rock3.9825 of 5 stars$43.42+1.3%$40.43-6.9%+148.8%$4.06B$33.19M-18.24140Positive NewsCRSPCRISPR Therapeutics2.5497 of 5 stars$44.33+0.2%$77.93+75.8%-32.8%$3.78B$200M-15.69473Analyst ForecastDNLIDenali Therapeutics4.4228 of 5 stars$23.13-0.7%$40.40+74.7%-0.5%$3.33B$330.53M-8.44364Positive NewsVCELVericel1.2886 of 5 stars$59.44+5.3%$59.71+0.5%+59.2%$2.93B$226.84M941.00300Analyst Forecast Related Companies and Tools Related Companies RVMD Alternatives HALO Alternatives KRYS Alternatives ADMA Alternatives ACLX Alternatives IMVT Alternatives SRRK Alternatives CRSP Alternatives DNLI Alternatives VCEL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRNG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
